Search

Search Results
Results 59561 - 59570 of 61352 for Cancer Research
  • News - 31 Jul 2007
    The maverick medics who are ophthalmic surgeons in Manchester are prescribing the drug Avastin to victims of the most common cause of blindness in the elderly, age-related macular degeneration (AMD).
  • News - 30 Jul 2007
    The linking of two signalling pathways in the cells of liver tumours has a clear influence on their malignancy. Activation of the platelet-derived growth factor (PDGF) messenger molecule is decisive...
  • News - 27 Jul 2007
    In the rancorous public debate over federal research funding, stem cells are generally assigned to one of two categories: embryonic or adult.
  • News - 27 Jul 2007
    A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to...
  • News - 26 Jul 2007
    Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical...
  • News - 26 Jul 2007
    Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by...
  • News - 25 Jul 2007
    The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II...
  • News - 24 Jul 2007
    A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.
  • News - 24 Jul 2007
    Not being able to read doesn't just make it harder to navigate each day. Low literacy impairs people's ability to obtain critical information about their health and can dramatically shorten their...
  • News - 23 Jul 2007
    Before the osteoporosis drug Evista is approved for breast cancer in the U.S. the Food and Drug Administration (FDA) will take the advice of an advisory panel.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.